ID   P388/ADR
AC   CVCL_IZ75
SY   P388/Adr; P388/adr
DR   ChEMBL-Cells; CHEMBL3307566
DR   ChEMBL-Targets; CHEMBL614218
DR   NCI-DTP; P388/ADR
DR   PubChem_Cell_line; CVCL_IZ75
DR   Wikidata; Q54937256
RX   PubMed=1849151;
RX   PubMed=3335022;
RX   PubMed=3402281;
CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7222 ! P388
SX   Female
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 7
//
RX   PubMed=1849151; DOI=10.1172/JCI115154;
RA   Gupta S., Kim J., Gollapudi S.;
RT   "Reversal of daunorubicin resistance in P388/ADR cells by
RT   itraconazole.";
RL   J. Clin. Invest. 87:1467-1469(1991).
//
RX   PubMed=3335022;
RA   Alley M.C., Scudiero D.A., Monks A., Hursey M.L., Czerwinski M.J.,
RA   Fine D.L., Abbott B.J., Mayo J.G., Shoemaker R.H., Boyd M.R.;
RT   "Feasibility of drug screening with panels of human tumor cell lines
RT   using a microculture tetrazolium assay.";
RL   Cancer Res. 48:589-601(1988).
//
RX   PubMed=3402281; DOI=10.1002/cyto.990090413;
RA   Ross D.D., Ordonez J.V., Joneckis C.C., Testa J.R., Thompson B.W.;
RT   "Isolation of highly multidrug-resistant P388 cells from
RT   drug-sensitive P388/S cells by flow cytometric cell sorting.";
RL   Cytometry 9:359-367(1988).
//